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Background: To improve the results of the classic periodontal treatment, probiotics have been suggested recently to 
decrease the number of bacteria and the expression of mediators of inflammation. This systematic review aimed to as-
sess the literature for the effectiveness of different probiotic strains as adjuvants to non-surgical periodontal therapy.
Material and Methods: The electronic database of MEDLINE (via Pubmed) was searched up to December 2017 
for randomised clinical trials in English comparing non-surgical periodontal treatment and probiotics versus peri-
odontal treatment and placebo. The primary outcome investigated was reduction in pocket probing depth. Second-
ary outcomes were bleeding on probing, plaque index reduction and bacteria counts.
Results: Nine trials were included. A narrative data synthesis did not result in any major improvement of overall 
pocket probing depth but moderate pockets from 4 to 6 mm showed larger reductions in study groups, which could 
decrease the need for surgery. Sites with bleeding on probing and presence of plaque decreased after treatment. 
For periimplant mucositis, there was a small tendency to better results in the study group.
Conclusions: With the available data, it is concluded that probiotics may provide an additional benefit to manual 
debridement in chronic periodontitis. More studies are required on dose, route of administration and strains of 
probiotics used.
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Introduction
Periodontal disease is defined as an inflammation of the 
supporting tissues of the teeth, leading to loss of bone 
and periodontal ligament. Some oral bacteria species, 
organised in biofilms, are considered one of the main 
etiologic factors, triggering a local destructive inflam-
matory reaction that creates periodontal pockets. Con-
ventional periodontal treatment is mainly comprised of 
mechanical debridement, since both the disruption of 
the biofilm and the restoration of a biologically accept-
able root surface are important in periodontitis progres-
sion (1). Thus, a probing pocket depth (PPD) reduction is 
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- Data items
The following items were recorded: year of publication, 
study design and duration; size of sample and stage of 
the disease; test and control interventions, including 
probiotic strains and any pre-treatment, vehicle, dose, 
frequency and length of consumption. We recorded the 
following outcomes: reduction in probing pocket depth, 
reduction of sites with bleeding on probing, reduction of 
plaque index scores, changes in bacteria concentration 
at any site of the oral cavity.
- Risk of bias in individual studies
The risk of bias of the individual studies was assessed 
according to the Cochrane Handbook for Systematic 
Reviews of Interventions (6) (high, unclear or low) ac-
cording to the assessment of the following items: gen-
eration of allocation sequences, allocation concealment, 
blinding of participants and personnel, blinding of out-
come assessment, incomplete outcome data, presence 
of biases in outcome reporting and other sources of bias 
that could influence the study’s validity. Studies were 
defined as low risk of bias if all criteria were met. When 
missing one of these criteria, the study was classified as 
moderate, and it resulted in a high potential risk when 
two or more were missing.
- Data analysis
Data extraction revealed considerable heterogeneity of 
the included studies so that a meta-analysis could not be 
carried out. Instead of that, data were pooled into tables 
and figures and a descriptive summary was generated 





From 74 identified studies, six papers fulfilled the eli-
gibility criteria, and three more studies were included 
from references. The flowchart of the retrieved studies 
is presented in Fig. 1.
normally taken as an indicator of treatment success and 
means good control over the inflammatory process (2).
To improve the results of the classic periodontal treat-
ment, some alternative therapies have been suggested 
recently to decrease the number of bacteria and the 
expression of mediators of inflammation. Preliminary 
studies show promising results using probiotics for oral 
diseases such as caries and candidiasis. Probiotics are 
living microorganisms which, when administered in 
adequate amounts, confer a health benefit for the host 
(3). However, there is in vitro and animal evidence that 
probiotic preparations comprised of dead cells and their 
metabolites can also exert a biological response (4). 
Probiotics’ exact mechanism of action in the oral cavity 
isn’t fully understood: there may be a direct interaction 
with the dental plaque, disrupting the biofilm owing to 
their antimicrobial products and competitive adhesion, 
and an indirect action as well, modulating the host’s im-
mune response.
The aim of this study was to review the adjuvant ef-
fects of different probiotic strains together with root 




This was a systematic review carried out using the 
PRISMA Statement as a reporting guide (5).
- Eligibility criteria
Only randomised clinical trials in English were con-
sidered. Eligible trials had to compare combined 
manual therapy and probiotics, or manual therapy and 
placebo. A reduction in probing pocket depth (PPD) 
was the main outcome measure. Secondary outcome 
measures were: bleeding on probing (BOP), plaque 
index (PI), and bacteria counting. Non-randomised 
clinical trials, studies conducted in animals and those 
including patients with a healthy periodontium or ex-
perimental gingivitis were excluded.
- Search strategy and study selection
We conducted an electronic search in Medline (via 
PUBMED) with controlled vocabulary (MeSH) using 
the following keywords: “Probiotics” and “Periodon-
tal Disease”, with no date restrictions. Last search was 
conducted in December of 2017. Relevant articles were 
selected and assessed, and cross-referencing from these 
sources was used to identify additional trials. The trials 
identified were screened by two independent reviewers 
to determine whether they met or not the inclusion cri-
teria. Any disagreement was resolved after discussion.
- Data collection process
Studies that fulfilled the inclusion criteria were pro-
cessed for quality assessment. Data were recorded ac-
cording to the criteria outlined by the Cochrane Col-
laboration, as done by other authors (6).
Fig. 1: Flowchart of the process of study selection.
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- Characteristics of studies included in the review
Nine randomised control trials published between 2013 
and 2016 were included. (3,7-14) Eight trials (3,7-13) 
used a parallel-arm design, and one of the studies (14) 
used a split-mouth design. Considerable heterogeneity 
was observed in all trials with respect to evaluation pe-
riod, age of participants and case definition (as some 
used Van der Welden’s (15) definition whereas others 
used Armitage’s (16)). The main characteristics of the 
studies are displayed in Table 1.
Table 1: Main characteristics of the included studies.







Case definition Probiotic (strain), 
dose of each strain 
per capsule
Intervention












S. uberis (KJ2), S. 
rattus (JH145)
≥108CFU/ml
OHI + full-mouth one-stage 
disinfection*
1 lozenge sucking/12h/3 
months








≥2 teeth with PD 
5-7mm in one ap-
proximal site




OHI + SRP (2 visits, 1-week 
intervals)
















OHI + full-mouth one-stage 
disinfection*
1 lozenge sucking/12h/3 
months












L. reuteri + L. sali-
varius
2x109 CFU/ml
OHI + SRP in two consecu-
tive days
Mouthwash 1/10ml 1’ twice a 
day for 2 weeks







≥5 teeth with PD 
≥5mm
BOP 20 ≥3mm
Bone loss in RX
L. rhamnosus SP1
2x107 CFU/ml
OHI + SRP in 4-6 visits at 
one-week intervals
SPT every 3 months
Lozenge in 150ml of water 
once a day for 3 months











OHI + SRP in two sessions at 
one-week intervals


















OHI + SRP in two quadrants
1 lozenge sucking/12h/21 
days from day 21









L. plantarum HK 
L-137
Not mentioned
OHI + SPT (once a month)
















OHI + manual debridement
Topical application with a 
probe
1 lozenge/12h/3 months
RCT= randomised controlled trial; CP= chronic periodontitis; OHI= oral hygiene instructions; SRP=scaling and root planning. *According to 
Quirynen et al.’s procedure.
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oral hygiene instructions before treatment, continued 
by a scaling and root planning in two consecutive days 
(3,7,8) according to Quirynen’s procedure (17) two ses-
sions at one-week intervals (9, 10) or four to six ses-
sions at one-week intervals (12). Only one study (12) 
performed supportive periodontal therapy (SPT) after-
wards, every three months during the evaluations. In 
one of the studies (11) all patients had undergone a peri-
odontal treatment before the start of the trial and were 
under an SPT program every month. Probiotic admin-
istration was started at the onset of the initial therapy 
in four studies (9-11,13), after the last session of scaling 
in four studies (3,7,8,12) and 21 days after treatment in 
one study (14). The administration routes were as fol-
lows: taking capsules (11), tablet dissolution in mouth 
(3,7,9,10,13,14), tablet dissolution in 150ml of water (12), 
subgingival irrigation plus mouthwash (8) and topical 
application of ointment (13). Treatment duration ranged 
from 3 weeks to 3 months (Table 1).
Side effects & industry funding
All studies evaluated the presence of side effects. No 
adverse events were reported during the follow-up pe-
riod. Study funding and supporting grants were men-
tioned in eight studies, (3,7-10,12-14) and in one study 
(11) it was not mentioned, and they stated to prepare 
their own probiotic product.
- Risk of bias assessment of selected studies
The estimated potential risk of bias was considered 
to be “low” in 6 studies (3,7,9-12), moderate in two 
(8,13) and high in Vivekananda’s (14) study.
- Study outcomes
Pocket probing depth (PPD)
Overall mean PPD at the beginning and at different 
time points is displayed in Table 2.
Subject characteristics
Sample sizes ranged between 28 and 49 participants, 
with an overall baseline sample size of 326 partici-
pants. A sum of nine patients were lost to follow up, 
in three studies (8,11,13). The gender distribution was 
mostly reported for the total sample, except in the study 
of Penala (8). Two studies (12,13) allowed for current 
smokers, whereas two exclude patients with a history 
of smoking (8,10), three exclude current smokers only 
(3,7,9) and one doesn’t mention this criterion (11). The 
effect of smoking status on the outcome parameters 
wasn’t subanalysed. Good general health was an inclu-
sion criterion for seven studies (3,7-10,12,14). Hallström 
et al. (13) excluded patients with a history of Diabetes 
mellitus only, and Iwasaki et al. (11) doesn’t mention 
anything about the baseline health status.
Case definition
Specific selected patients diagnosed with untreated 
chronic periodontitis were included in seven of the stud-
ies (3,7-10,12,14). One of these studies (8) used the pres-
ence of clinically perceptible halitosis estimated on an 
organoleptic score as an additional inclusion criterion. 
One study (11) took patients undergoing a supportive 
periodontal therapy (SPT) with an initial PD of ≥4mm. 
Patients with periimplantitis in at least one implant (a 
PD≥4mm and presence of pus or bleeding) were includ-
ed in the study of Hallström et al. (13) As the definition 
of chronic periodontitis differs between all studies, it is 
shown in Table 1.
Probiotics and intervention procedures
The strains of probiotics used were: L. reuteri 
(7,9,10,13,14), L. reuteri plus, L. salivarius (8), Strep-
tococcus oralis, S. uberis and S. ratus (3), L. rhamno-
sus (12) and L. plantarum (11). All patients were given 
Group Time point
BL 3 weeks 12 weeks 24 weeks 1 year









































































BL: baseline. Statistically significant results are shown in bold. aValues represent PPD reduction.
Table 2: Intergroup comparison of overall PPD (mm) reported at different time points (mean ± SD).
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Mean baseline PPD ranges between 2,17±0,36 and 
5,57±0,39 mm in the control group and 2,21±0,32 and 
5,85±0,54mm for the study group. At 12 weeks, val-
ues range from 0,69±0,38 to 4,75±0,48 mm and from 
0,76±0,43 to 4,25±0,41 mm for the control and study 
groups respectively. Statistically significant differ-
ences in favour of the study group were seen in two 
studies at all time points (p<0,001) (9,10).
Four out of five studies that evaluated PPD reduction in 
moderate pockets (4-6 mm) found statistically signifi-
cant differences between the control and study groups, 
with greater reductions for the study group. (7-9,11) One 
study (3) found a greater reduction in the control group, 
which was not significant (Table 3).
Plaque index (PI)
Four trials (3,7,12,13) used a dichotomous measurement 
for supragingival plaque accumulation and reported % 
of positive sites to plaque presence. Five trials (8-11,14) 
report the mean of Löe and Silness’ index (18). Larger 
reductions in plaque index are seen for study group in 
seven studies (3,7-10,12,14) but three of them (7,8,12) 
didn’t find intergroup differences (Fig. 3).




















a Measurement at 3 months; b Measurement at 12 months; ns= non-
significant
Table 3: PPD reduction (mm) in moderate pockets (4-6mm) for each 
group at the end of the study.
Bleeding on probing (BOP)
The reduction in % of sites with BOP ranges between 
3,70-59,5% and 0,70-77,85% for the control and study 
groups respectively. For chronic periodontitis, there 
is greater reduction in % of sites with BOP at all 
time points with the use of probiotics in five studies 
(7,9,10,12,14). Despite this tendency, only three trials 
(9,10,14) found statistically significant differences when 
compared to the control group (p<0,005 (9),  p<0,05 
(10) and  p<0,001 (14)) (Fig. 2). Better results with the 
use of probiotics have been reported as well when us-
ing the bleeding index of Saxton, with a mean reduction 
of 1,34 and 1,08 (p<0,002) (8). Two studies reported a 
larger reduction in the control group which wasn’t sta-
tistically significant: 3,7% vs 0,7% (11) and 48±19% vs 
47±17% (3) in control and study groups respectively. For 
periimplant mucositis, BOP sites were reduced from 54 
to 14% in the study group and from 58 to 17% of sites in 
the control group, which was a statistically significant 
reduction from baseline but not between groups.
Fig. 2: Reduction in bleeding on probing (% of sites) for chronic 
periodontitis.
Fig. 3: Reduction of % of sites with plaque accumulation and reduc-
tion of mean plaque index (Löe and Silness plaque index).
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Biochemical and microbiological parameters
There is a significant reduction in red complex micro-
organisms at 1 month, which was higher for the study 
group, according to the BANA test (8). Between-group 
comparisons show a higher reduction of Aggregati-
bacter actinomycetencomitans, Porphyromonas gingi-
valis and Prevotella intermedia in subgingival plaque 
at 6-week evaluation for the study group (p<0,005, 
p<0,005 and p<0,05 respectively) (14), less concentra-
tion of Prevotella intermedia in saliva samples (p<0,02) 
(3) and of Porphyromonas gingivalis in saliva, supra-
gingival and subgingival plaque (7). Halitosis score, 
assessed subjectively on a scale of 0 to 5, showed bet-
ter results with the adjunctive use of probiotics (from 
4±0,93 to 0,4±0,51 in the test group and from 4,43±0,51 
to 1,21±0,89 in the control group) (8). One study (10) re-
ported a significant decrease in MMP-8 and significant 
increase in TIMP-1 concentrations that was superior for 
all time intervals in the study group except day 360.
Discussion
Chronic periodontitis is a multifactorial disease that 
arises from the interaction between three key factors: 
bacteria, the host’s immune response and the environ-
ment. Initial therapy consists of a manual debridement 
of the periodontal pocket and oral hygiene instructions, 
in order to decrease the number of pathogenic bacteria. 
However, this shift to a less pathogenic microbiota is 
only temporary, even when combined with antiseptics 
or antibiotics (7). Probiotics seem to confer a beneficial 
effect to many infectious diseases, including those of 
the oral cavity. A direct interaction with pathogenic 
flora, a modulation of the immune response and the 
synthesis of antimicrobial products seem to be some 
of their mechanisms. Most studies conducted in hu-
mans use Lactobacillus and Bifidobacterium spp, even 
though other species such as Bacillus spp have shown 
promising results in experimental periodontitis in ani-
mals through the production of spores (19). Lactobacil-
lus reuteri forms reuterin (3-hydroxipropionaldehyd), 
which induces oxidative stress in cells (9). Other sug-
gested effects are: ability to compete with pathogens 
for epithelial cell adhesion (10), a reduction in the pro-
duction of proinflammatory cytokines (TNF-α, IL-1β, 
IL-17), (20) a reduction in MMP-8 expression, which is 
the main collagenase involved in chronic periodontitis, 
and an increase of TIMP-1, which is a modulating factor 
of MMP activity. (10) On the other hand, Streptococ-
cus sanguinis and Streptococcus uberis form hydrogen 
peroxide, a product that inhibits the growth of Aggre-
gatibacter actinomycetencomitans (3). Such biological 
interactions could have a beneficial impact in clinical 
parameters of patients with chronic periodontitis.
No additional benefit is seen in terms of mean PPD ex-
cept for the studies of Tekce et al. (9) and Ince et al. (10). 
These studies have deeper baseline PPD and this could 
have influenced the greater differences between groups. 
Nevertheless, subanalyses show that different strains of 
Lactobacillus seem to decrease PPD in moderate peri-
odontal pockets (4-6 mm) when compared to the use 
of placebo + SRP (7-9,11). This effect is not seen in the 
study of Laleman et al. (3) with the use of Streptococcus 
spp even though the inclusion criteria and intervention 
were identical to Teughels et al.’s (7) who used of L. 
reuteri. This could mean data obtained in vitro and in 
animal studies doesn’t necessarily need to show ben-
eficial results in humans, and not all strains of probi-
otics might be effective. Interestingly, two trials (9,11) 
have less significant reductions than other authors. In 
the study of Tekce et al. (9), measurements took place at 
360 days and without any periodontal support therapy. 
It could be possible that the beneficial effects of probi-
otics on moderate pockets were temporary and did not 
last for more than 3 months. In the study of Iwasaki et 
al. (11) mean values reported were not for mean PPD of 
pockets with 4-6mm but for PPD of teeth with pockets 
with 4-6mm and that is why the baseline mean wasn’t 
over 3,08±0,34 mm for any group, compared with the 
other studies. Also, their patients were under a support-
ive periodontal therapy, meaning baseline periodontal 
pockets were not deep and probiotics might not be ben-
eficial in such cases.
Statistically significant differences are seen in inter-
group comparisons for BOP in favour of the use of 
Lactobacillus spp, but this was not seen after the use of 
Streptococcus spp (3). Iwasaki et al. (11) found no sig-
nificant differences in this clinical parameter between 
the two groups (3,70 and 0,7% reduction for the con-
trol and study group respectively). Interestingly, their 
patients were under a SPT program, which includes 
a reinforcement of oral hygiene instructions, and this 
may have influenced such low bleeding throughout the 
study. Another study to perform SPT after the treatment 
was that carried out by Morales et al. (12). Similarly, 
the reduction in BOP was 8,30% for the control group 
and 11,70% for the study group. Tekce et al. (9) and 
Ince et al. (10) measure BOP at one year after 3-week 
consumption of L. reuteri lozenges with no additional 
TPS and obtain a reduction of 69,6% and 50,95% in 
the control group and 77,85% and 77,3% in the study 
group respectively. Teughels et al. (7) showed less BOP 
on the study group but didn’t obtain statistically signifi-
cant differences at 3-month evaluation despite using a 
similar methodology than the aforementioned studies. 
Also, administration routes other than lozenge dissolu-
tion have shown promising results according to Penala 
et al. (8) whose patients were told to mouthwash with a 
L. reuteri and L. salivarius product.
Microbiological and chemical effects are not reported 
in all trials. Vivekananda (14) was the first author to 
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suggest L. reuteri’s antimicrobial effect in short-term 
measurements in a split-mouth study, reporting that 
probiotic lozenges either alone or in combination with 
SRP decreased the counts of subgingival A. actinomy-
cetencomitans, P. gingivalis and P. intermedia. Similar 
results for subgingival plaque were obtained by Tekce et 
al. (9) who reported larger reductions in obligate anaer-
obes at days 21, 90 and 180, but showed no difference 
between groups at day 360, suggesting the beneficial ef-
fects of probiotics are temporary. According to Teughels 
et al. (7), larger reductions in P. gingivalis were found in 
subgingival, supragingival and saliva samples over the 
12-week period, as well as a reduction in P. intermedia 
in supragingival (p=0,074) and saliva (p<0,05) samples. 
On the other hand, Streptococcus spp. antimicrobial ef-
fect is not clear as Laleman et al. (3) found a significant 
intergroup difference only for P. intermedia in saliva 
at week 12 (p=0,02) but did not find any difference for 
other anaerobe microorganisms, and no further inves-
tigation on the presence of the probiotic subgingivally 
was conducted. Little is known about the subgingival 
retention of the delivered probiotic as only the paper of 
Tekce et al. (9) considers this parameter. In his study, L. 
reuteri was detected in 6 and 11 patients the day 21 and 
90 respectively, but the levels decreased by the end of 
the evaluation period. This indicates that probiotic col-
onization isn’t immediate, is only temporary and isn’t 
seen in all patients, what could explain differences in 
microbiological differences between studies.
When analysing the effect of probiotics in the manage-
ment of periimplant mucositis, Hallström et al. (13) 
performed a manual debridement combined with pro-
fessional topical application of a L. reuteri gel and pre-
scription of L. reuteri lozenges twice a day for three 
months. They reported a general improvement in both 
the test and placebo groups, with a change in PPD at 
the implant’s deepest site of 0,7-1,2 mm in both groups. 
Bleeding on probing was reduced in 40 and 41% in 
study and control groups respectively. They found a 
tendency to greater reduction in IL-1RA, IL-8, CCL5, 
TNF-α and GM-CSF in the crevicular fluid, but inter-
group comparisons were not statistically significant for 
any parameter.
Conclusions
Probiotics may provide a safe additional benefit to man-
ual debridement in clinical and biochemical parameters 
of chronic periodontitis. Nevertheless, more studies are 
required with larger cohorts on dose, route of adminis-
tration and strains of probiotics used.
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